FDA Approves Device for Pancreas Care - Top_Thought_Leaders - MDSpire

FDA Approves Device for Pancreas Care

In the phase 3 PANOVA-3 trial, adding Tumor Treating Fields therapy to gemcitabine and nab-paclitaxel was associated with improved overall survival and delayed pain progression in adults with locally advanced pancreatic cancer.

  • By

  • Kathryn Wighton

  • February 12, 2026

  • 3 min

Share

Top Thought Leaders in General Medicine

Brief introduction explaining scope and methodology.

Original Source(s)

FDA Approves Device for Pancreas Care

  • by Kathryn Wighton

  • February 12, 2026

Related Content

AI Model May Help Decipher Malignant, Benign Breast Lesions on MRI

Model matches deep-learning accuracy and helps physicians reclassify benign breast lesions.

3 Medical Routines That Older People May Not Need

“The treatment may be more burdensome than the condition itself."

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.